VJHemOnc is committed to improving our service to you

CAR-T Meeting 2020 | How can CAR-T cells sensitivity and affinity be improved?

VJHemOnc is committed to improving our service to you

Johannes Huppa

Johannes Huppa, PhD, Medical University of Vienna, Vienna, Austria, explains how a better understanding of T-cells can improve the sensitivity and affinity of CAR T-cell therapy. Dr Huppa believes that in order to achieve these, we have most likely to shift away from current formats of CARs and move towards the T-cell receptor. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter